FDA approves Menveo quadrivalent meningococcal vaccine in children starting as early as two months
The Food and Drug Administration (FDA) approved the expanded age range for Menveo quadrivalent meningococcal vaccine for infants and toddlers from 2 months of age, according to a FDA approval letter. Neisseria More...